Gene · 699
Papers3,725
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 3,725
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Retinoblastoma: A review of the molecular basis of tumor development and its clinical correlation in shaping future targeted treatment strategies. | Indian J Ophthalmol | 2023 | 37417104 | PubTator, text mining | PubMed |
| Functional role of MicroRNA/PI3K/AKT axis in osteosarcoma. | Front Oncol | 2023 | 37404761 | PubTator, text mining | PubMed |
| Centrosome linker diversity and its function in centrosome clustering and mitotic spindle formation. | EMBO J | 2023 | 37401899 | PubTator, text mining | PubMed |
| Budding uninhibited by benzimidazoles-1 (BUB1) regulates EGFR signaling by reducing EGFR internalization. | Aging (Albany NY) | 2023 | 37399454 | PubTator, text mining | PubMed |
| Multiplex single-cell chemical genomics reveals the kinase dependence of the response to targeted therapy. | bioRxiv | 2023 | 37398090 | PubTator, text mining | PubMed |
| In Silico Discovery of 5'-Modified 7-Deoxy-7-ethynyl-4'-thioadenosine as a HASPIN Inhibitor and Its Synergistic Anticancer Effect with the PLK1 Inhibitor. | ACS Cent Sci | 2023 | 37396870 | PubTator, text mining | PubMed |
| Hyperplastic Human Macromass Cartilage for Joint Regeneration. | Adv Sci (Weinh) | 2023 | 37395375 | PubTator, text mining | PubMed |
| A novel camptothecin derivative, ZBH-01, exhibits superior antitumor efficacy than irinotecan by regulating the cell cycle. | J Transl Med | 2023 | 37386467 | PubTator, text mining | PubMed |
| Targeting lysine-specific demethylase 1 (KDM1A/LSD1) impairs colorectal cancer tumorigenesis by affecting cancer cells stemness, motility, and differentiation. | Cell Death Discov | 2023 | 37385999 | PubTator, text mining | PubMed |
| RETRACTED: Expression of microRNAs and their target genes in melanomas originating from gynecologic sites. | PLoS One | 2023 | 37384650 | PubTator, text mining | PubMed |
| Reviewing Atrial Fibrillation Pathophysiology from a Network Medicine Perspective: The Relevance of Structural Remodeling, Inflammation, and the Immune System. | Life (Basel) | 2023 | 37374146 | PubTator, text mining | PubMed |
| Apoptosis Related Human Wharton's Jelly-Derived Stem Cells Differentiation into Osteoblasts, Chondrocytes, Adipocytes and Neural-like Cells-Complete Transcriptomic Assays. | Int J Mol Sci | 2023 | 37373173 | PubTator, text mining | PubMed |
| Target 2035 - an update on private sector contributions. | RSC Med Chem | 2023 | 37360399 | PubTator, text mining | PubMed |
| Dedifferentiation and Proliferation of Artery Endothelial Cells Drive Coronary Collateral Development in Mice. | Arterioscler Thromb Vasc Biol | 2023 | 37345524 | PubTator, text mining | PubMed |
| Budding uninhibited by benzimidazoles 1 promotes cell proliferation, invasion, and epithelial-mesenchymal transition via the Wnt/β-catenin signaling in glioblastoma. | Heliyon | 2023 | 37342577 | PubTator, text mining | PubMed |
| Analysis of the potential relationship between COVID-19 and Behcet's disease using transcriptome data. | Medicine (Baltimore) | 2023 | 37335738 | PubTator, text mining | PubMed |
| The role of AFAP1-AS1 in mitotic catastrophe and metastasis of triple-negative breast cancer cells by activating the PLK1 signaling pathway. | Oncol Res | 2023 | 37305386 | PubTator, text mining | PubMed |
| Comprehensively analyzing the genetic alterations, and identifying key genes in ovarian cancer. | Oncol Res | 2023 | 37304238 | PubTator, text mining | PubMed |
| A Multi-Omics Overview of Colorectal Cancer to Address Mechanisms of Disease, Metastasis, Patient Disparities and Outcomes. | Cancers (Basel) | 2023 | 37296894 | PubTator, text mining | PubMed |
| Identification of immune-related gene signature for predicting prognosis in uterine corpus endometrial carcinoma. | Sci Rep | 2023 | 37286702 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/699/papers?page=18